Titan America SA Common Shares (TTAM)
14.01
-0.04 (-0.28%)
NYSE · Last Trade: Jun 10th, 2:27 PM EDT

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a modest opening, just slightly higher than its initial pricing.
Via Talk Markets · February 9, 2025